Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study
Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
Department of Ophthalmology, University of Tokyo, Tokyo, Japan; Santen Inc., Emeryville, CA, United States; Santen Pharmaceutical Co., Ltd., Osaka, Japan